Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ-Reference-Cited by-同舟云学术

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ

Published:2019-10-17 Issue:2 Volume:34 Page:293-300
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Masson Regnault M.¹,Castañeda‐Sanabria J.²,Diep Tran M.H.T.²,Beylot‐Barry M.³,Bachelez H.⁴⁵⁶,Beneton N.⁷,Chosidow O.⁸,Dupuy A.⁹,Joly P.¹⁰,Jullien D.¹¹,Mahé E.¹²,Richard M.‐A.¹³,Viguier M.¹⁴,Tubach F.²¹⁵,Sbidian E.⁸,Paul C.¹,

Affiliation:

1. Dermatologie CHU Toulouse Toulouse France

2. Centre de Pharmaco‐épidémiologie, Pitié Salpêtrière Paris France

3. Dermatologie CHU Bordeaux Bordeaux France

4. Service de Dermatologie AP‐HP Hopital Saint Louis Paris France

5. Sorbonne Paris Cité Université Paris Diderot Paris France

6. UMR INSERM 1163 Institut Imagine Paris France

7. Dermatologie CHU Le Mans Le Mans France

8. Dermatologie, AP‐HP, Hôpitaux universitaires Henri Mondor Département de Dermatologie UPEC INSERM Centre d'Investigation Clinique 1430 EA 7379 EpidermE Université Paris‐Est Créteil, UPEC Créteil France

9. Dermatologie CHU Rennes Rennes France

10. Dermatologie CHU Rouen Rouen France

11. Dermatologie CHU Lyon Lyon France

12. Dermatologie CH Argenteuil Argenteuil France

13. Dermatology Department EA 3279: CEReSS ‐ Health Service Research and Quality of Life Center Timone Hospital, Assistance Publique Hôpitaux de Marseille Aix‐Marseille University Marseille France

14. Dermatologie‐Vénéréologie Hôpital Robert Debré Reims France

15. Sorbonne Université, INSERM UMR‐S 1136 Paris France

Funder

AbbVie

Pfizer

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15878

Reference21 articles.